Mitral Regurgitation



Fig. 16.1
Echocardiography, four-chamber view. From left to right: two-dimensional imaging shows thickened mitral leaflet with posterior leaflet prolapse (arrow). Color Doppler shows severe eccentric mitral regurgitation swirling toward interatrial septum and reaching the pulmonary veins (Coandă effect, arrow point). Nyquist limit is shifted downward to detect proximal isovelocity surface area (PISA) >1 cm (star)



Normal and trileaflet aortic valve. Normal aorta. Moderate dilatation of the left atrium (LA diameter M-mode = 4.5 cm; area 4c = 26 cm2). Eccentric hypertrophy of the left ventricle (with end diastolic diameter 60 mm). Normal systolic function (ejection fraction 60 % measured with Simpson’s biplane) without focal hypokinesia or akinesia. Thickened mitral leaflet with severe prolapse of the posterior leaflet and mild prolapse of the anterior leaflet. Severe eccentric mitral regurgitation (vena contracta 7.5 mm, PISA 1.1 cm, effective regurgitant orifice area (EROA) 0.5 mm2). Normal right atrium (area 4c = 17 cm2). Restrictive mitral inflow pattern (grade III diastolic dysfunction). Normal tricuspid valve. Mild tricuspid regurgitation which was centrally directed with an estimated PASP = 50 mmHg. Normal pulmonic valve. Normal interatrial septum. Normal pericardium. Normal aorta. Slightly dilated inferior vena cava. Less than 50 % inspiratory collapse of the IVC.

Mitral regurgitation had major hemodynamic consequences in this patient and led to atrial enlargement due to chronic volume overload. Ventricular hypertrophy was probably the consequence of either hypertension or mitral insufficiency. These alterations led to the development of heart failure. The presence of cardiac remodeling suggested a chronic valve disease, and even if the symptoms arose 3 months before, severe insufficiency was probably present since several months or years. Myxoid degeneration of valve apparatus (Barlow disease) was the probable mechanism of valve disease. No alterations suggesting endocarditis were found. Ventricle was dilated, but the extent of dilatation wasn’t sufficient to consider valve insufficiency as secondary.



Final Diagnosis


Congestive heart failure due to a severe mitral valve prolapse and regurgitation


What Should the Cardiologist Do?






  • Refer the patient for cardiac surgery.


  • Treat the patient for heart failure.


  • Treat the patient with drugs and reevaluate after 3 months.

Cardiac surgery in primary mitral regurgitation is curative and the occurrence of symptoms is a major indication for surgery. The presence of increased PASP is a further indication for surgery. Medical therapy may alleviate symptoms, but reduction of valve regurgitation is unlikely (which is possible in secondary MR). Hence evaluation for cardiac surgery, including coronary angiography for the detection of asymptomatic coronary artery disease, is the right choice. Concurrent medical therapy for heart failure, including diuretics, beta-blockers, and ACE inhibitors or ARBs, is important until cardiac surgery is undertaken.



16.2 Mitral Regurgitation



Definition and Classification


Mitral regurgitation (MR) is characterized by a systolic blood flow reversal from the left ventricle (LV) to the left atrium (LA). MR can be classified based on etiology and mechanisms. The etiology of MR is generally stratified as ischemic that occurs in up to 40 % of patients affected by myocardial infarction [1] and nonischemic. Mechanisms of MR are stratified as functional (mitral valve is structurally normal and MR is due to valve deformation caused by ventricular remodeling) or as organic (intrinsic valve lesions). A further classification of MR, according to Carpentier, is by observation of leaflet movement: type I (normal valve movement such as annular dilatation, perforation), type II (excessive movement), and type III (restrictive movement: IIIa, diastolic restriction such as rheumatic disease; IIIb, systolic restriction as in functional MR) (Table 16.1).


Table 16.1
Severity of mitral regurgitation in adults











































 
Mild

Moderate

Severe

LV and LA size

Normal size LV


LV and LA enlarged

Vena contracta

<3

3–6.9

>7

PISAr (Nyquist limit of 40 cm/s)

<0.4 cm
 
>1 cm

Regurgitant volume

<30 ml/bpm

30–59 ml/bpm

>60 ml/bpm

Regurgitant fraction

<30 %

30–49 %

>50 %

Regurgitant orifice area

<0.20 cm2

0.20–0.39 cm2

>0.40 cm2


Etiology


The mitral valve apparatus is made of the leaflets, the annulus, the chordae, the papillary muscles, and the left ventricular wall [2]. When one of these portions of the apparatus becomes abnormal, MR may develop. Also left ventricle dilatation or papillary muscle displacement can provoke the dysfunction of the mitral valve apparatus.

As seen above, the etiology of MR can be stratified into nonischemic and ischemic.

Nonischemic etiologies include:

(a)

Degenerative MR includes myxomatous degeneration of the mitral valve with resultant mitral valve prolapse with or without ruptured chordae, mitral valve leaflet sclerosis or calcification, and mitral annulus calcification.

 

(b)

Rheumatic MR is usually due to commissure fusion in chronic type, while in pure active rheumatic MR, annulus dilatation and anterior leaflet prolapse from chordal elongation are described [3].

MR etiology is predominantly degenerative in developed countries and rheumatic in developing countries:

 

(c)

Infective endocarditis (5 % of severe MR) that causes MR mainly through tissue destruction.

 

(d)

Congenital lesions (isolated cleft mitral valve or associated with persistent atrioventricular canal, corrected transposition with or without Ebstein’s abnormality of the left atrioventricular valve).

 

(e)

Iatrogenic (radiation/drugs).

 

(f)

Cardiac tumors.

 

(g)

Other causes (connective tissue diseases, systemic lupus erythematosus, antiphospholipid antibody syndrome, cardiac trauma, hypertrophic cardiomyopathy or sarcoidosis, eosinophilic syndromes, endocardial fibroelastosis, carcinoid tumors).

Ischemic etiologies include papillary muscle (PPM) displacement, leaflet tethering, and annular dilatation. Functionally the leaflets present a restricted systolic motion due to tethering forces that displace the coaptation surface toward the left ventricle (LV) apex [4].

 

According to the classification of the mechanisms of MR, it is possible to distinguish two types of pathologies: functional MR and organic MR. While the former includes all forms of MR that are not secondary to alterations of the valve per se, the latter is due to primary mitral valve disease (fusion of commissures, annulus dilatation, leaflet prolapse, chordal elongation, retractile fibrosis, etc.).

Even if etiology and mechanism are not synonymous (a single etiology may generate MR by different mechanisms), the mechanism of ischemic and functional MR is similar; in fact mitral leaflets are intrinsically normal, but their coaptation is incomplete [5] because of annular and left ventricular dilatation due to ischemia, previous myocardial infarction and scarring, aneurysm formation, cardiomyopathy, or myocarditis.


Pathophysiology


Anatomic malcoaptation of mitral leaflets during systole results in a regurgitant orifice (ERO), which under the influence of the pressure gradient between the LV and LA allows abnormal regurgitant flow into the LA. The systolic pressure gradient between the LV and LA begins when mitral valve closes (S1) and persists after aortic valve closure (S2) up to mitral opening [6]. Thus, regurgitant flow is typically holosystolic. The regurgitant flow throughout systole is the regurgitant volume (RVol) accumulated in the LA, which reenters the LV during the next diastole, causing a volume overload of LA and LV.

Determinants of this volume overload are the area of ERO [7], the regurgitant gradient, and duration of regurgitation. In both organic MR [8] and functional MR [9], ERO increases when afterload increase and decreases with afterload reduction or improved contractility. Its change is independent of rate [8]. The consequences of volume overload of the LA and LV are different depending on the fact that regurgitation is acute or chronic. In acute severe MR, the left ventricle responds to the sudden volume overload with increased sarcomere stretch and augmented left ventricular stroke volume (Frank-Starling mechanism). The larger volume increases left ventricular diastolic pressure, which in turn increases left atrial pressure. However, left atrial compliance is normal in the acute state and the large regurgitant volume markedly increases left atrial pressure. This phenomenon causes pulmonary congestion, edema, and dyspnea. Otherwise, chronic MR progresses slowly, so the LA has enough time to remodel and accommodate the RVol with a near normal LA pressure. As a result, clinical tolerance may be excellent [10]. In these patients, the Frank-Starling mechanism continues to augment total stroke volume. The left atrium dilates, thus increasing its compliance. The blood that reflows from a dilated left ventricle to a dilated atrium provokes only a small rise of filling pressures, with minimal symptoms of pulmonary congestion (chronic compensated stage).

LV dysfunction (chronic decompensated stage) is a frequent complication of severe MR that occurs if the disease is not treated properly during the reversible phase [11, 12]. It is associated with myocardial structural damage as interstitial fibrosis and reduction in myofiber content that provokes decrease in myofiber contractility [13] and increase in left ventricular filling pressures and finally pulmonary congestion. A downward cycle is now activated: increased ventricular pressure further dilates the left ventricle, increasing systolic wall stress and afterload, which in turn reduces ventricular systolic function. The time during which patients progress from compensated to decompensated MR depends on some variables as the severity of the regurgitation, afterload, and ventricular contractility.

In ischemic/functional MR, blood regurgitation is provoked by tethering and tenting of the leaflets and loss of coaptation surface [14, 15] due to localized LV deformation with apical and posterior displacement of the papillary muscles. The RVol in ischemic MR is usually less than in organic MR [16], and LV dilatation and LA dilatation are in excess to the degree of MR [7], due to the presence of a dilatated, poor performant heart.


Clinical Manifestations


Chronic MR is a slow process that allows a gradual LA enlargement and a consequent increase in LA compliance that permits to maintain a normal or near normal LA pressure. For this reason, patients may remain asymptomatic for years despite severe MR. However, once symptoms arise, fatigue and generalized weakness predominate early. As left ventricular function deteriorates, exertional dyspnea, orthopnea, and paroxysmal nocturnal dyspnea become more prominent. Frank pulmonary edema or hemoptysis may also develop and is usually triggered by atrial fibrillation or increase in the degree of MR. Sudden death as the initial presentation of MR is possible [17].


Diagnosis



Symptoms


Clinical manifestations of mitral regurgitation (MR) are related to the severity of regurgitation, the rate of progression, and the associated cardiopathy.

Acute MR due to chordal rupture (flail), endocarditis, or trauma leads to an increase in left atrial pressure due to a volume overload in a noncompliant left atrium. Pulmonary edema or cardiogenic shock may be the presenting symptoms owing to elevated filling pressures and low cardiac output. The dramatic increase of pulmonary pressure may also cause right heart failure.

Chronic MR leads to a progressive left atrial enlargement without elevated left atrial pressure. Patients usually remain asymptomatic for years unless there is left ventricular (LV) failure. Dyspnea and fatigue gradually worsening over the years are the most frequent symptoms.


Physical Examination


MR is usually diagnosed by auscultation. S1 may be diminished due to the failure in the closure of the mitral valve. A soft systolic murmur, best heard at the apex and radiated to the axilla, is the most frequent finding, but its timing and intensity depend on severity and mechanisms of MR. The murmur has little variations with respiration and becomes louder when the preload (i.e., raising legs) or afterload (i.e., squatting) increases. Sometimes the systolic murmur isn’t audible even in the presence of moderate or severe MR (silent MR), especially in ischemic MR, owing to a low pressure gradient between the left ventricle and atrium (low systemic blood pressure with elevated LA pressure). A systolic click may suggest a valve prolapse, while a thrill or S3 suggests a severe regurgitation.
< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 10, 2016 | Posted by in CARDIOLOGY | Comments Off on Mitral Regurgitation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access